Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

NCT03490669 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Pancreatic Cancer
Non Small Cell Lung Cancer
Ovarian Cancer

Interventions

BIOLOGICAL: MSC-1

Sponsor

AstraZeneca